Anti-idiotypic antibodies against anti-GPRC5D antibodies
Number of patents in Portfolio can not be more than 2000
United States of America
Stats
-
Jul 9, 2024
Grant Date -
N/A
app pub date -
Jul 15, 2021
filing date -
Jul 15, 2021
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
In certain aspects, the disclosure relates to anti-idiotype antibodies and antigen-binding portions thereof that specifically bind a GP5B83 containing protein, e.g., an antibody or antigen-binding portions thereof. In some aspects, the anti-idiotype antibodies and antigen-binding portions of the present disclosure can be used in methods to detect and quantify cells expressing chimeric antigen receptors that include GP5B83.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully